Prexasertib dimesylate (LY2606368 dimesylate) is a highly selective, ATP-competitive, second-generation inhibitor of checkpoint kinase 1 (CHK1), with a K_i of 0.9 nM and an IC_50 of <1 nM, and also effectively inhibits CHK2 (IC_50 = 8 nM) and RSK1 (IC_50 = 9 nM). Its mechanism induces double-stranded DNA breakage and replication catastrophe, leading to apoptosis, and demonstrates potent anti-tumor activity.
Molecular Weight:
557.6
CAS Number:
[1234015-58-7]
Formula:
C20H27N7O8S2
Target:
Apoptosis|||Chk|||Others
T38620
* VAT and and shipping costs not included. Errors and price changes excepted
